In contrast to AML cells, however, there was no difference in the cytarabine sensitivity between B-ALL and T-ALL cell lines and no correlation between SAMHD1 expression and cytarabine sensitivity in ALL cells (Fig. 2, Supplementary Fig. 6). The gene discussed is SAMHD1; the disease is acute myeloid leukemia.